Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will present at the Benzinga Global Small Cap Conference taking place virtually on Dec. 8-9, 2020. Genprex’s president and CEO, Rodney Varner, will deliver a company overview that includes recent progress the company has made on its…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that it will participate in a fireside chat hosted by IPO Edge in partnership with The Palm Beach Hedge Fund Association, a Florida trade association for financial professionals and ultra-high-net-worth investors. The chat, titled “Security Robots of the Future,”…
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced an expanded partnership with KeHE, which now includes the A88CBD(TM) topical products, A88 Infused(TM) flavors and the entire Alkaline88(R) line, including eco-friendly aluminum bottles. “KeHE has been an exceptional partner in our…
Net Element (NASDAQ: NETE) is transforming its business model to enter the electric vehicle (“EV”) industry through a reverse-merger with California-based Mullen Technologies Inc. The strategic move positions the company to benefit amid the dropping price of EV batteries, which has decreased 87% in less than a decade (https://ibn.fm/GRCa9) and is projected to drop even…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure and intense shearing forces, the platform creates unique, high-quality nanoemulsions that have enormous use in a wide variety of industries.…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that its virtual Special Meeting of Stockholders, which was scheduled for Dec. 1, 2020, was held but no business was conducted because a full quorum was not in attendance. The meeting has been rescheduled for…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, today announced that it will host the 13th Annual LD Micro Main Event, a prominent two-day virtual investor conference, via its Sequire Virtual Events platform. The event is slated to be held on Dec. 14 – 15,…
Blue Hat Interactive (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, has signed a definitive agreement for the acquisition of 51% of Fuzhou Csfctech Co. Ltd. The agreement also includes Csfctech’s two subsidiaries. A developer and distributor of mobile games in China, Csfctech offers…
WrapTechnologies (NASDAQ:WRAP), an innovator of modern policing solutions, announced that BolaWrap(R), its patented, hand-held remote restraint device, was used by the Virginia Police Department in Minnesota earlier this month. The successful deployment of the revolutionary device was captured on bodycam video footage, which WRAP will release today. The footage will be shown during a live…
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, on Monday announced its commencement of clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small cell lung cancer (“NSCLC”). The company’s timing of patient recruitment and enrollment keeps it on track for its Acclaim-1 clinical…
VistaGen Therapeutics (NASDAQ: VTGN) has appointed a new vice president of translational medicine. A pioneer in the development of neuroactive steroids known as pherines, Louis Monti, MD., PhD., developed the original scientific platform that enabled the early research and development of VistaGen’s PH94B and PH10. The two intranasal neuroactive steroid drug candidates (pherines) have potential…
Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced that it was featured in a new video interview with SNN Network, “The Official Small-, Micro- and Nano-Cap News Source(TM).” According to the update, Jupiter Wellness CEO Brian John and chairman and Chief Scientific Officer Dr. Glynn Wilson…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that the first two patients have been dosed in Turkey for its Phase 2 trial. The trial evaluates its investigational drug, MS1819, in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy (“PERT”), for…
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that its Nasdaq ticker symbol is set to change from “WRTC” to “WRAP” beginning at market open on Tuesday, December 1, 2020. “We are excited to align the new ticker symbol ‘WRAP’ directly to our corporate brand and strengthen our visibility with public…
Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health care platform, is ideally situated as the global pandemic has led to a cascade of changes involving how health care is administered, perhaps most notably in the increased adoption of telehealth services. Trxade Group’s business model appears to aptly and effectively meet today’s demands, largely…
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be providing its digital therapeutics solution to qualified employees of a U.S.-based Fortune 500 technology company. The contract, which goes into effect on Jan. 1, 2021, with the beginning of a new benefits year, calls for Dario to provide its digital diabetes tools…
Jupiter Wellness (NASDAQ: JUPW), a developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced initiation of a clinical study of its CaniSun(TM) sunscreen lotion for the treatment of actinic keratosis (“AK”), the most common precancer that forms on the skin as a result of exposure to ultraviolet (“UV”) rays. The clinical study’s primary…
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that, in celebration of its recently completed initial public offering, it will ring the Nasdaq Stock Exchange opening bell…
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a recent article published in the Korea Biomedical Review. The piece, titled “Yuhan emerges as global new-drug developer with $3.6 billion tech export,” discusses Yuhan Corp.’s (OCT:…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into an agreement with three preschools (the First and Fourth Preschools and the Children’s Center) of Guangzhou Development District Talent Work Group of Augmented Reality…